Get started
Author

Amy Dawson

Observed names: A. Dawson, A.L. Dawson, Dawson, Amy
ORCID: 0000-0002-5207-7988
Observed ORCID: 0000-0002-5207-7988
OpenAlex ID: A5023701192
Genomic analysis of low‐grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities
2020 · Dane Cheasley, Abhimanyu Nigam, et al. · The Journal of Pathology · 129
Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development
2018 · Amy Dawson, Marta Llauradó Fernandez, et al. · ecancermedicalscience · 104
PDF
A microfluidic chip based model for the study of full thickness human intestinal tissue using dual flow
2016 · A. Dawson, C. Dyer, et al. · Biomicrofluidics · 51
PDF
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target
2019 · Marta Llaurado Fernandez, Amy Dawson, et al. · Cancer Cell International · 45
PDF
Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma
2020 · Marta Llaurado Fernandez, Amy Dawson, et al. · Gynecologic Oncology · 44
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability
2021 · Raunak Shrestha, Marta Llaurado Fernandez, et al. · Cancer Research · 42
PDF
Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines.
2016 · Marta Llauradó Fernández, Gabriel E DiMattia, et al. · PubMed Central · 42
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
2022 · Dane Cheasley, Marta Llaurado Fernandez, et al. · npj Precision Oncology · 30
PDF
Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes
2020 · Stephanie A. Scott, Marta Llaurado Fernandez, et al. · Gynecologic Oncology · 28
FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma
2025 · Yuen Yee Leung, Marta Llaurado-Fernandez, et al. · Journal of Gynecologic Oncology · 24
Lab-on-a-chip workshop activities for secondary school students
2016 · Mohammad M. N. Esfahani, Mark D. Tarn, et al. · Biomicrofluidics · 17
PDF
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2022 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al. · Molecular Cancer Therapeutics · 16
PDF
Microfluidics : the fur-free way towards personalised medicine in cancer therapy
2016 · Amy Dawson, John Greenman, et al. · Repository@Hull (Worktribe) (University of Hull) · 4
PDF
Paper microfluidics for clinical diagnostics using colourimetric detection methods
2014 · Amy Dawson · Repository@Hull (Worktribe) (University of Hull) · 2
Targeted therapy in low-grade serous ovarian carcinoma : characterization of MEK inhibitor response in novel patient-derived cell lines
2017 · Dawson, Amy · cIRcle (University of British Columbia) · 1
PDF
Supplementary Data from NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2023 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al.
Supplementary Data from NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2023 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al.
Supplementary Figure from NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2023 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al.
Supplementary Data from NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2023 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al.
Supplementary Figure from NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2023 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al.
PDF
Supplementary Data from NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2023 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al.
Supplementary Data from NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2023 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al.
Data from NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2023 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al.
Data from NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2023 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al.
Data from Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability
2023 · Raunak Shrestha, Marta Llaurado Fernandez, et al.
Works count: 44
Citation count: 579
H-index: 12
I10-index: 12
Year
Topic
Type